AUR vs. CLOV

In the year-to-date period, AUR achieves a 7.94% return, which is significantly lower than CLOV's 39.37% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Aurora Innovation, Inc. (AUR) and Clover Health Investments, Corp. (CLOV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current AUR Sharpe Ratio is 1.18, which is lower than the CLOV Sharpe Ratio of 4.08. The chart below compares the historical Sharpe Ratios of AUR and CLOV, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither AUR nor CLOV has paid dividends to shareholders.

The maximum AUR drawdown since its inception was -93.34%, roughly equal to the maximum CLOV drawdown of -97.19%. Use the drawdown chart below to compare losses from any high point for AUR and CLOV. For additional features, visit the drawdowns tool.

Aurora Innovation, Inc. (AUR) has a higher volatility of 37.44% compared to Clover Health Investments, Corp. (CLOV) at 14.49%. This indicates that AUR's price experiences larger fluctuations and is considered to be riskier than CLOV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Aurora Innovation, Inc. and Clover Health Investments, Corp.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.